Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Daniel G. Eramian currently holds 354,350 shares of CELL THERAPEUTICS INC (CTIC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel G. Eramian has been a net seller of CTIC stock. They have purchased $0 and sold $326.5K worth of shares.
Daniel G. Eramian's most recent insider trade was on Sep 20, 2012, when they sold 15,000 shares at $2.68 per share.
Daniel G. Eramian serves as Executive at CELL THERAPEUTICS INC (CTIC). They have executed 39 insider transactions totaling $326.5K over their tenure at the company.
Daniel G. Eramian holds the position of Executive at CELL THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Daniel G. Eramian has shown a selling trading pattern, with $0 in total purchases and $326.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Daniel G. Eramian was on Jul 31, 2009, when they sold $347.9K worth of CTIC shares. This transaction involved 235,064 shares at $1.48 per share.
Daniel G. Eramian currently owns 354,350 shares of CELL THERAPEUTICS INC (CTIC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Daniel G. Eramian's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Daniel G. Eramian has 39 Form 4 filings on record as an insider at CELL THERAPEUTICS INC.
Set alerts for Daniel G. Eramian and 40,000+ other insiders.